Quote For Boston Scientific Corporation BSX.N
sector: Healthcare ·
industry: Advanced Medical Equipment ·
$8.59
2 Dec 2009
+1.78%
$8.44
$8.48
4,560,800
$8.63
$8.44
$11.77
$5.80
1.13
17,026,374
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Nicholas, Peter |
Chairman of the Board |
1,265,810 |
| Elliott, Ray |
President, Chief Executive Officer |
-- |
| Leno, Sam |
Chief Financial Officer, Executive Vice President - Finance and Information Systems |
6,321,260 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$12,748.03 |
| Shares Outstanding (Mil.) |
1,510.43 |
| Float (Mil.) |
1,450.81 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
1.42 |
| Current Ratio |
1.56 |
| LT Debt/Equity |
43.42 |
| Total Debt/Equity |
45.35 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
1.57 |
| Price/Book(TTM) |
0.96 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-1.58 |
| Sales(TTM) |
$5.38 |
| Book Value(MRQ) |
$8.80 |
| Cash Flow(TTM) |
$-1.08 |
| Cash(MRQ) |
$0.91 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-16.41 |
| Return on Assets(TTM) |
-8.49 |
| Return on Investment(TTM) |
-9.64 |
| |
|
| Margins |
| Gross Margin(TTM) % |
69.23 |
| Operating Margin(TTM) % |
-26.03 |
| Profit Margin(TTM) % |
-29.33 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives